赫斯1
Notch信号通路
骨肉瘤
癌症研究
JAG1
转移
生物
基质凝胶
信号转导
细胞周期蛋白依赖激酶8
Hes3信号轴
癌变
细胞生长
医学
癌症
槽口1
病理
肿瘤进展
肿瘤微环境
细胞
细胞生物学
血管生成
遗传学
作者
Pingyu Zhang,Yanwen Yang,Patrick A. Zweidler‐McKay,Dennis P.M. Hughes
标识
DOI:10.1158/1078-0432.ccr-07-1992
摘要
Abstract Purpose: Notch signaling is an important mediator of growth and survival in several cancer types, with Notch pathway genes functioning as oncogenes or tumor suppressors in different cancers. However, the role of Notch in osteosarcoma is unknown. Experimental Design: We assessed the expression of Notch pathway genes in human osteosarcoma cell lines and patient samples. We then used pharmacologic and retroviral manipulation of the Notch pathway and studied the effect on osteosarcoma cell proliferation, survival, anchorage-independent growth, invasion, and metastasis in vitro and in vivo. Results: Notch pathway genes, including Notch ligand DLL1, Notch1 and Notch2, and the Notch target gene HES1, were expressed in osteosarcoma cells, and expression of HES1 was associated with invasive and metastatic potential. Blockade of Notch pathway signaling with a small molecule inhibitor of γ secretase eliminated invasion in Matrigel without affecting cell proliferation, survival, or anchorage-independent growth. Manipulation of Notch and HES1 signaling showed a crucial role for HES1 in osteosarcoma invasiveness and metastasis in vivo. Conclusion: These studies identify a new invasion and metastasis-regulating pathway in osteosarcoma and define a novel function for the Notch pathway: regulation of metastasis. Because the Notch pathway can be inhibited pharmacologically, these findings point toward possible new treatments to reduce invasion and metastasis in osteosarcoma.
科研通智能强力驱动
Strongly Powered by AbleSci AI